MagForce AG
MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of brain tumors; NanoPlan, a software that supports the attending physician in preparing the ideal treatment …
Medical - Instruments & Supplies
DE, Berlin [HQ]
Ratios
13 Sheets · From 2021 to 2009Configuration
Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||
| Gross Margin | - - | - - | -707.37 | - - | - - | - - | -14.87 | -21.24 | 4.67 | -577.60 | 106.39 | 69.98 | -89.95 | |
| Profit Margin | - - | - - | -20,946.92 | - - | - - | - - | -60.05 | -1,526.31 | -1,042.45 | 6,485.20 | -1,039.44 | 2,374.12 | -3,004.20 | |
| Operating Margin | - - | - - | -18,516.02 | - - | - - | - - | -72.82 | -1,257.79 | -1,034.84 | 10,161.22 | -685.74 | 2,997.64 | -1,913.88 | |
|
EPS Growth
|
2.70 | -75.93 | -9.47 | 48.08 | 93.70 | 42.21 | -53.69 | -363.58 | - - | 157.14 | -300.00 | 256.25 | -70,758.00 | |
| EPS EUR | -108.00 | -190.00 | -208.00 | -108.00 | -6.80 | -3.93 | -6.04 | -28.00 | -28.00 | 16.00 | -32.00 | 50.00 | -35,329.00 | |
| Return on Assets (ROA) | -124.59 | -202.25 | -297.85 | -29.19 | -9.18 | -3.51 | -6.22 | -35.66 | -33.88 | 11.74 | -23.82 | 22.48 | -16.83 | |
| Return on Equity (ROE) | 42.70 | 62.38 | 52.48 | 17.74 | -10.68 | -4.13 | -6.76 | -46.21 | -56.58 | 24.00 | -59.36 | 41.52 | -39.40 | |
| Return on Invested Capital (ROIC) | 35.06 | 54.58 | 46.40 | 14.60 | -8.69 | -1.73 | -8.20 | -38.08 | -39.84 | 20.01 | -18.35 | 31.91 | -12.84 | |
| Solvency | ||||||||||||||
| Equity Ratio | -200 | -300 | -500 | -100 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | - - | - - | - - | - - | - - | - - | - - | - - | 24.57 | 42.97 | 45.50 | 34.81 | 40.82 | |
| Debt/Equity | - - | - - | - - | - - | - - | - - | - - | - - | 41.02 | 87.88 | 113.40 | 64.29 | 95.56 | |
| Debt/EBITDA | 27.44 | 16.04 | 0.20 | 15.58 | 775.83 | 4,520.36 | 142.23 | 12.15 | -79.62 | 187.83 | -318.81 | 107.12 | -453.53 | |
|
Debt/Capitalization
|
- - | - - | - - | - - | - - | - - | - - | - - | 29.09 | 46.77 | 53.14 | 39.13 | 48.86 | |
| Long-Term Debt/Capitalization | - - | - - | - - | - - | - - | - - | - - | - - | 29.09 | 46.65 | 53.13 | 39.13 | 48.86 | |
| Interest Debt per Share EUR | 0.19 | 0.24 | 0.24 | 0.19 | 0.01 | - - | - - | - - | 0.22 | 0.67 | 0.66 | 0.88 | 955.17 | |
| Debt Growth | - - | - - | - - | - - | - - | - - | - - | - - | - - | 193.33 | 5.02 | 36.90 | 12.33 | |
| Liquidity | ||||||||||||||
| Current Ratio | 11.70 | 11.13 | 3.82 | 718.46 | 764.47 | 509.29 | 842.76 | 48.05 | 100.99 | 298.43 | 58.20 | 100.96 | 19.26 | |
| Quick Ratio | 6.90 | 6.95 | 0.08 | 27.51 | 689.22 | 361.81 | 820.14 | 37.27 | 74.03 | 249.81 | 1,114.54 | 1,584.36 | 843.83 | |
| Cash Ratio | 6.90 | 6.69 | 0.08 | 27.51 | 689.22 | 358.57 | 220.48 | 19.21 | 49.43 | 167.30 | 5.79 | 45.38 | 1.69 | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | ||||||||||||||
| Inventory Turnover | - - | 700.03 | - - | - - | - - | 74.95 | 3,664.26 | 806.22 | 226.43 | 156.45 | -16.21 | 55.46 | 227.42 | |
| Receivables Turnover | - - | - - | - - | - - | - - | - - | 67.99 | 82.07 | 216.22 | 9.12 | 77.55 | 45.60 | 43.56 | |
| Payables Turnover | 238.86 | 83.80 | 19.51 | 17.84 | 47.18 | 85.09 | 566.32 | 220.77 | 273.12 | 133.66 | -7.92 | 61.79 | 103.17 | |
|
Asset Turnover
|
- - | - - | 1.42 | - - | - - | - - | 10.36 | 2.34 | 3.25 | 0.18 | 2.29 | 0.95 | 0.56 | |
| Fixed Turnover | - - | - - | 1.93 | - - | - - | - - | 57.32 | 12.78 | 19.95 | 1.98 | 26.03 | 17.22 | 11.78 | |
| Coverage | ||||||||||||||
| Interest Coverage | -458.60 | -699.26 | -763.45 | -464.27 | -479.00 | -1,187.74 | -2,714,625.57 | -11,225.00 | -2,795.61 | 374.60 | -342.25 | 612.94 | -229.08 | |
| Asset Coverage | - - | - - | - - | - - | - - | - - | - - | - - | 300 | 200 | 100 | 200 | 200 | |
| Cash Flow Coverage (CFGR) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| EBITDA Coverage | -400 | -600 | -700 | -400 | -400 | -500 | -1,419,400 | -9,500 | -2,200 | 400 | -300 | 600 | -100 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | - - | - - | - - | 500 | - - | - - | - - | - - | - - | - - | - - | |
| Market Prospects | ||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | -2.57 | -9.26 | -34.68 | -47.80 | -1.52 | -0.80 | -1.10 | -6.20 | -4.41 | 3.07 | -7.88 | 10.09 | -12,988.52 | |
|
Price/Earnings (P/E)
|
-3,889.29 | -1,079.95 | -288.33 | -209.19 | -6,570.26 | -12,580.26 | -9,094.36 | -1,612.21 | -2,265.93 | 3,260.87 | -1,269.34 | 991.43 | -0.77 | |
| Price/Earnings Growth (PEG) | 1,439.04 | -14.22 | -30.43 | 4.35 | 70.12 | 298.07 | -169.39 | -4.43 | - - | -20.75 | 4.23 | -3.87 | - - | |
|
Price/Book (P/B)
|
-1,660.90 | -673.70 | -151.31 | -37.12 | 701.85 | 519.21 | 614.78 | 744.95 | 1,282.12 | 782.59 | 753.47 | 411.67 | 0.30 | |
| Price/Tangible Book (P/TB) | -1,660.90 | -673.70 | -151.31 | -37.12 | 701.85 | 519.21 | 614.78 | 744.95 | 1,282.12 | 782.59 | 753.47 | 411.67 | 0.30 | |
| Price/Sales (P/S) | - - | - - | 60,395.72 | - - | - - | - - | 5,460.98 | 24,607.23 | 23,621.15 | 211,474.13 | 13,194.03 | 23,537.82 | 23.13 | |
|
Price/Cash Flow (P/CF)
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -31,677,945.53 | |
| Price/Free CF (P/FCF) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -31,677,945.53 | |
| Price/Operating CF (P/OCF) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -31,677,945.53 |